Search research articles
Contact Us
Filters
Showing results (81-90 of 84) with videos related to
Page
of 9
Sort By:
You have reached the last page of results.
This site can display upto 84 results.
Journal of Medicinal Chemistry
|
November 20, 2023
Discovery of 5-(Pyrimidin-2-ylamino)-1<i>H</i>-indole-2-carboxamide Derivatives as Nur77 Modulators with Selective and Potent Activity Against Triple-Negative Breast Cancer
Jingbo Qin, Boning Niu, Xiaohui Chen, et al.
Nature Communications
|
November 26, 2021
Interrogation of the microenvironmental landscape in spinal ependymomas reveals dual functions of tumor-associated macrophages
Qianqian Zhang, Sijin Cheng, Yongzhi Wang, et al.
Clinical Chemistry and Laboratory Medicine
|
July 17, 2020
A systematic evaluation of stool DNA preparation protocols for colorectal cancer screening via analysis of DNA methylation biomarkers
Shengnan Jin, Qian Ye, Yanping Hong, et al.
Journal of Cellular and Molecular Medicine
|
April 16, 2017
miR-495 sensitizes MDR cancer cells to the combination of doxorubicin and taxol by inhibiting MDR1 expression
Zhenyou Zou, Ruyi Zou, Dan Zong, et al.
Page
of 9
Search research articles
Search
Showing results (81-90 of 84) with videos related to
Sort By:
Page
of 9
You have reached the last page of results.
This site can display upto 84 results.
Journal of Medicinal Chemistry
|
November 20, 2023
Discovery of 5-(Pyrimidin-2-ylamino)-1<i>H</i>-indole-2-carboxamide Derivatives as Nur77 Modulators with Selective and Potent Activity Against Triple-Negative Breast Cancer
Jingbo Qin, Boning Niu, Xiaohui Chen, et al.
Nature Communications
|
November 26, 2021
Interrogation of the microenvironmental landscape in spinal ependymomas reveals dual functions of tumor-associated macrophages
Qianqian Zhang, Sijin Cheng, Yongzhi Wang, et al.
Clinical Chemistry and Laboratory Medicine
|
July 17, 2020
A systematic evaluation of stool DNA preparation protocols for colorectal cancer screening via analysis of DNA methylation biomarkers
Shengnan Jin, Qian Ye, Yanping Hong, et al.
Journal of Cellular and Molecular Medicine
|
April 16, 2017
miR-495 sensitizes MDR cancer cells to the combination of doxorubicin and taxol by inhibiting MDR1 expression
Zhenyou Zou, Ruyi Zou, Dan Zong, et al.
Page
of 9